Biomedical Diagnostics LLC, Biotherapies, Genesis Bioventures deal

GBI acquired the 50% stake in Biomedical Diagnostics it did not already own from Biotherapies for shares and cash. Under the acquisition, Biotherapies, in which GBI holds a 26% stake, will sublicense ...